Trial Profile
A phase II multicenter study of XEN 2174 for acute postoperative pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2010
Price :
$35
*
At a glance
- Drugs XEN 2174 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use